Aristocort (triamcinolone acetonide) is a mid-potency topical corticosteroid formulated to reduce inflammation, itching, and redness associated with various dermatological conditions. Trusted by dermatologists for decades, it offers targeted relief with a well-established efficacy and safety profile when used as directed. This product card provides comprehensive medical information for healthcare professionals and informed patients.

Features

• Active ingredient: Triamcinolone acetonide (0.025%, 0.1%, 0.5% concentrations)
• Available formulations: Cream, ointment, lotion
• Rapid absorption and onset of action
• Minimal systemic absorption with appropriate use
• Preservative-free options available
• Suitable for short-term and intermittent long-term therapy

Benefits

• Effectively reduces inflammation and associated symptoms like itching and swelling
• Provides rapid symptomatic relief for acute flare-ups
• Helps restore skin barrier function in eczematous dermatoses
• Multiple formulations allow for tailored treatment based on skin type and condition
• Established safety profile with decades of clinical use
• Cost-effective compared to newer branded alternatives

Common use

Aristocort is commonly prescribed for inflammatory dermatoses including atopic dermatitis, contact dermatitis, psoriasis, lichen planus, and nummular eczema. It is also used off-label for certain autoimmune blistering diseases and granulomatous conditions when inflammation is a primary component. The choice of formulation (cream, ointment, or lotion) depends on the lesion type, location, and patient preference.

Dosage and direction

Apply a thin film to the affected area 2-4 times daily, depending on severity. For most dermatoses, twice-daily application provides optimal results. Use the lowest effective potency and frequency to control symptoms. Occlusive dressings may be used for resistant plaques but increase absorption and side effect risk. Treatment duration should generally not exceed 2 weeks without medical supervision. For pediatric use, limit application to the smallest area and shortest duration possible.

Precautions

Avoid use on facial and intertriginous areas unless specifically directed. Do not use under occlusive dressings unless prescribed, as this increases systemic absorption. Discontinue if irritation develops. Use with caution in patients with liver impairment. Monitor for signs of hypothalamic-pituitary-adrenal (HPA) axis suppression with prolonged use. Not for ophthalmic use. Pregnancy Category C: use only if potential benefit justifies potential risk.

Contraindications

Hypersensitivity to triamcinolone acetonide or any component of the formulation. Contraindicated in viral skin infections (herpes simplex, varicella), fungal infections, and untreated bacterial infections. Avoid use in rosacea, perioral dermatitis, and acne vulgaris. Not recommended for use in children under 2 years except under strict medical supervision.

Possible side effect

Common: Burning, itching, irritation, dryness, folliculitis. Less common: Hypopigmentation, hypertrichosis, striae, skin atrophy. Rare: Allergic contact dermatitis, miliaria, telangiectasia. Systemic effects including HPA axis suppression may occur with excessive use, especially under occlusion or on large surface areas.

Drug interaction

No significant drug interactions have been reported with topical use. However, concurrent use with other topical products may increase irritation or affect absorption. Avoid concomitant use with other topical corticosteroids unless specifically directed. Caution advised when using with other medications that affect skin integrity.

Missed dose

Apply as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed application. Maintain regular application schedule for optimal results. If multiple doses are missed, contact healthcare provider for guidance.

Overdose

Topical overdose may cause systemic corticosteroid effects including Cushing’s syndrome, hyperglycemia, and HPA axis suppression. Acute overdose is unlikely with appropriate use. If excessive application occurs, wipe off excess product and monitor for systemic symptoms. Seek medical attention if signs of systemic corticosteroid effects appear.

Storage

Store at room temperature (15-30°C). Keep tube tightly closed. Protect from freezing and excessive heat. Do not store in bathroom where moisture may affect stability. Keep out of reach of children and pets. Discard any product that has changed color, consistency, or odor.

Disclaimer

This information is for educational purposes only and does not replace professional medical advice. Always consult a healthcare provider for diagnosis and treatment recommendations. Use only as directed by a qualified medical professional. Individual results may vary.

Reviews

Clinical studies demonstrate Aristocort’s efficacy in reducing EASI scores by 60-75% in moderate atopic dermatitis over 2-4 weeks. Dermatologists consistently rate it as a reliable mid-potency option with predictable results. Patients report significant improvement in itching and sleep quality within the first week of appropriate use. Long-term safety data supports its use for intermittent therapy in chronic conditions.